A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy Participants
Clinical trial NCT04464239 · COMPLETED
Trial details
- NCT number
- NCT04464239
- Sponsor
- Taisho Pharmaceutical R&D Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2021-01-21
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.